HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

picene

structure given in first source

Also Known As:

benzo(a)chrysene

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Phenanthrenes: 27
        Chrysenes
        picene: 5
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Phenanthrenes: 27
    - Chrysenes
      - picene: 5

Experts

1.	Gohda, Shin: 1 article (05/2011)
2.	Komura, Noriko: 1 article (05/2011)
3.	Kubozono, Yoshihiro: 1 article (05/2011)
4.	Okamoto, Hideki: 1 article (05/2011)
5.	Satake, Kyosuke: 1 article (05/2011)
6.	Sato, Kaori: 1 article (05/2011)
7.	Sugino, Hisako: 1 article (05/2011)
8.	Yamaji, Minoru: 1 article (05/2011)
9.	Flesher, James W: 1 article (01/2002)
10.	Horn, Jamie: 1 article (01/2002)

Related Diseases

1.	Carcinogenesis 10/01/1990 - "Initiation of tumorigenesis in the two-stage tumor model with 7,12-dimethylbenz[a]anthracene (1 mumol/animal) and chronic treatment with picene (total dose 4.8 mumol) for 24 weeks was equally ineffective in producing tumors in NMRI mice. " 01/01/1988 - "The lacking carcinogenicity of picene could therefore result from the inability of microsomal enzymes to transform its M-region dihydrodiol to dihydrodiol bay-region epoxides in amounts necessary to initiate carcinogenesis."
2.	Sarcoma (Soft Tissue Sarcoma) 01/11/2002 - "Similar treatment with picene did not induce sarcoma in any test animals by 37 weeks (0%). "
3.	Photosensitivity Disorders (Photodermatitis) 05/20/2011 - "A facile formation of picene was achieved by photosensitization of 1,2-di(1-naphthyl)ethane using 9-fluorenone as a sensitizer. "
4.	Papilloma (Papillomatosis) 10/01/1990 - "Epicutaneous application of both PAHs (600 nmol/animal) followed by chronic treatment with 12-O-tetradecanoyl-phorbol-13-acetate for 24 weeks led to the formation of papillomas in 93% of animals treated with DBA while picene showed no tumorigenic activity at all. " 10/01/1990 - "Chronic epicutaneous application of both PAHs (total dose 1.36 mumol) to the back of mice resulted in the development of papillomas with a tumor rate of 22% in the case of picene and of 32% in the case of DBA. "
5.	Neoplasms (Cancer) 10/01/1990 - "Histopathological examination of the tumors in the three experimental models revealed no difference in the type of tumor between picene and DBA. " 10/01/1990 - "Chronic epicutaneous application of both PAHs (total dose 1.36 mumol) to the back of mice resulted in the development of papillomas with a tumor rate of 22% in the case of picene and of 32% in the case of DBA. " 10/01/1990 - "Initiation of tumorigenesis in the two-stage tumor model with 7,12-dimethylbenz[a]anthracene (1 mumol/animal) and chronic treatment with picene (total dose 4.8 mumol) for 24 weeks was equally ineffective in producing tumors in NMRI mice. "

Related Drugs and Biologics

1.	anthracene
2.	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
3.	Proteins (Proteins, Gene)
4.	Perylene
5.	Methylcholanthrene
6.	Mixed Function Oxygenases (Monooxygenases)
7.	Hydrocarbons
8.	Epoxy Compounds (Epoxides)
9.	Enzymes
10.	Carrier Proteins (Binding Protein)